Drugs / Ortho-R
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT05333211 | Jul 2022 → Dec 2023 | rotator cuff syndrome | ChitogenX Inc | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ortho-R | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05333211 ↗ |
| Modality | Other / unclassified | “freeze-dried drug/biologic combination product” NCT05333211 ↗ |